Biocomposites invests in Renovos Biologics - developers of the RENOVITE® nanoclay therapeutic delivery platform ...Middle East

RENOVITE ® nanoclay is a novel therapeutic delivery platform for precision regenerative medicine Investment will help fund pre-market approval for use in spine, trauma and orthopaedics Biocomposites, CEO, Michael Harris will join Renovos Biologics Board of Directors KEELE, England, July...

Hence then, the article about biocomposites invests in renovos biologics developers of the renovite nanoclay therapeutic delivery platform was published today ( Wednesday 05/07/2023 - 10:41 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Biocomposites invests in Renovos Biologics - developers of the RENOVITE® nanoclay therapeutic delivery platform )

Also on site :

• Another Weight Loss Surgery and a Wedding Bombshell: Spoilers From '1000-Lb Sisters' Season 8 Episode 2
• Trump-Iran latest: President threatens ‘very strong action’ if protesters are hanged after forced confessions
• Saks Global Secures $1.75 Billion of Committed Capital and Announces Return of Industry Veterans to Advance Transformation of Iconic Luxury Portfolio